SCHEDULE 13D/A Filed 2026-05-27 Event 2026-05-22 SEC 0001123292-26-000750 →

GILEAD SCIENCES, INC. → ASSEMBLY BIOSCIENCES, INC. ASMB

Stake: 25.10% Shares: 4,977,089 CUSIP: 045396108 Class: Common Stock, par value $0.001

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 14.70

2,312,058 shares short · -4.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $20.43M

Point72 Asset Mgmt

Post-Filing Returns · since 2026-05-22 on ASMB

+1 day

+1.4%

+5 days

-3.3%

+30 days

-11.3%

+60 days

-6.6%

+90 days

—

+180 days

—

Anchor price 28.34 on closest trading day on/after 2026-05-22. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on ASSEMBLY BIOSCIENCES, INC.

Filed	Form	Filer	Stake	Shares
2024-06-20	SC	GILEAD SCIENCES, INC.	—	—	view →

Other Filings by GILEAD SCIENCES, INC.

Filed	Form	Issuer	Stake	Shares
2026-04-28	SCHEDULE 13D/A	Arcellx, Inc.	—	100	view →
2025-02-20	SCHEDULE	Arcus Biosciences, Inc. RCUS	35.00%	39,691,649	view →
2025-01-10	SCHEDULE	GALAPAGOS NV GLPGF	29.90%	20,981,010	view →
2024-06-20	SC	ASSEMBLY BIOSCIENCES, INC. ASMB	—	—	view →
2023-07-06	SC	Arcus Biosciences, Inc. RCUS	—	—	view →
2021-02-02	SC	Arcus Biosciences, Inc. RCUS	—	—	view →
2019-08-29	SC	GALAPAGOS NV GLPGF	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →